Skip to Main Content

Paper Details

Early safety indicators of COVID-19 convalescent plasma in 5000 patients.
J Clin Invest
322
2020
COVID-19, Diabetes, Digestive and Kidney Diseases, allergic transfusion reactions, convalescent plasma, coronavirus disease, critically, human, patients, transfusion-associated circulatory overload, transfusion-related acute lung injury
Adolescent, Adult, Aged, Aged, 80 and over, Betacoronavirus, COVID-19, COVID-19 Serotherapy, Compassionate Use Trials, Coronavirus Infections, Female, Humans, Immunization, Passive, Male, Middle Aged, Pandemics, Pneumonia, Viral, SARS-CoV-2, Safety, Transfusion Reaction, Transfusion-Related Acute Lung Injury, United States, United States Food and Drug Administration, Young Adult
Author NameAffiliation
Michael J Joyner
R. Scott Wright
R. Scott WrightMayo Clinic
DeLisa Fairweather
Jonathon W Senefeld
Katelyn A Bruno
Stephen A Klassen
Rickey E CarterMayo Clinic
Allan M Klompas
Chad C Wiggins
John Ra Shepherd
Robert F Rea
Emily R Whelan
Andrew J Clayburn
Matthew R SpiegelMayo Clinic
Patrick W JohnsonMayo Clinic
Elizabeth R LesserMayo Clinic
Sarah E Baker
Kathryn F Larson
Juan G Ripoll
Kylie J Andersen
David O HodgeMayo Clinic
Katie L KunzeMayo Clinic
Matthew R BurasMayo Clinic
Matthew N P Vogt
Vitaly Herasevich
Joshua J Dennis
Riley J Regimbal
Philippe R BauerMayo Clinic
Janis E BlairMayo Clinic
Camille M van BuskirkMayo Clinic
Jeffrey L WintersMayo Clinic
James R StubbsMayo Clinic
Nigel Paneth
Nigel PanethCollege of Human Medicine, Michigan State University
Nigel Paneth
Nigel PanethCollege of Human Medicine, Michigan State University
Nicole VerdunCenter for Biologics Evaluation and Research
Peter MarksCenter for Biologics Evaluation and Research
Arturo CasadevallJohns Hopkins Bloomberg School of Public Health
Arturo CasadevallJohns Hopkins Bloomberg School of Public Health
  • 1 - 41

Datasets

Release 1.2